cancer

Open Access
Nanobody nuclear imaging allows noninvasive quantification of LAG-3 expression by tumor-infiltrating leukocytes and predicts response of immune checkpoint blockade
Quentin Lecocq, Robin Maximilian Awad, Yannick De Vlaeminck, Wout De Mey, Thomas Ertveldt, Cleo Goyvaerts, Geert Raes, Kris Thielemans, Marleen Keyaerts, Nick Devoogdt and Karine Breckpot

Journal of Nuclear Medicine March 26, 2021, jnumed.120.258871; DOI: https://doi.org/10.2967/jnumed.120.258871
You have access
Optical Imaging Modalities: Principles and Applications in Preclinical Research and Clinical Settings
Giacomo Pirovano, Sheryl Roberts, Susanne Kossatz and Thomas Reiner

Journal of Nuclear Medicine October 1, 2020, 61 (10) 1419-1427; DOI: https://doi.org/10.2967/jnumed.119.238279
You have access
⁸⁹Zr Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression
Kyung-Ho Jung, Jin Won Park, Jin Hee Lee, Eun Ji Lee, Seung Hwan Moon, Young Seok Cho and Kyung-Han Lee

Journal of Nuclear Medicine September 11, 2020, jnumed.120.250720; DOI: https://doi.org/10.2967/jnumed.120.250720
You have access
Imaging the Distribution of Gastrin-Releasing Peptide Receptors in Cancer
Lucia Baratto, Heying Duan, Helmut Mäcke and Andrei Iagaru

Journal of Nuclear Medicine June 1, 2020, 61 (6) 792-798; DOI: https://doi.org/10.2967/jnumed.119.234971
You have access
Long-Term Clinical and Neuronuclear Imaging Sequelae of Cancer Therapy, Trauma, and Brain Injury
April Alcantara, Gholam R. Berenji, Carole S. Scherling, Beata Durcanova, Daniel Diaz-Aguilar and Daniel H.S. Silverman

Journal of Nuclear Medicine December 1, 2019, 60 (12) 1682-1690; DOI: https://doi.org/10.2967/jnumed.119.237578
You have access
Prediction of Time to Hormonal Treatment Failure in Metastatic Castration-Sensitive Prostate Cancer with ¹⁸F-FDG PET/CT
Hossein Jadvar, Erik M. Velez, Bhushan Desai, Lingyun Ji, Patrick M. Colletti and David I. Quinn

Journal of Nuclear Medicine November 1, 2019, 60 (11) 1524-1530; DOI: https://doi.org/10.2967/jnumed.118.223263
Open Access
Tumor Imaging Using Radiolabeled Matrix Metalloproteinase–Activated Anthrax Proteins
Mary-Ann Elvina Xavier, Shihui Liu, Thomas H. Bugge, Julia Baguña Torres, Michael Mosley, Samantha L. Hopkins, Phillip D. Allen, Georgina Berridge, Iolanda Vendrell, Roman Fischer, Veerle Kersemans, Sean Smart, Stephen H. Leppla and Bart Cornelissen

Journal of Nuclear Medicine October 1, 2019, 60 (10) 1474-1482; DOI: https://doi.org/10.2967/jnumed.119.226423
You have access
Early Postoperative ¹⁸F-FET PET/MRI for Pediatric Brain and Spinal Cord Tumors
Lisbeth Marner, Karsten Nysom, Astrid Sehested, Lise Borgwardt, René Mathiasen, Otto Mølby Henriksen, Michael Lundemann, Per Munck af Rosenschöld, Carsten Thomsen, Lars Bøgeskov, Jane Skjøth-Rasmussen, Marianne Juhler, Anders Kruse, Helle Broholm, David Scheie, Torsten Lauritsen, Julie Lyng Forman, Peder Skov Wehner, Liselotte Højgaard and Ian Law

Journal of Nuclear Medicine August 1, 2019, 60 (8) 1053-1058; DOI: https://doi.org/10.2967/jnumed.118.220293
You have access
Quantitative Tumor Perfusion Imaging with ⁸²Rb PET/CT in Prostate Cancer: Analytic and Clinical Validation
Mads R. Jochumsen, Lars P. Tolbod, Bodil G. Pedersen, Maria M. Nielsen, Søren Høyer, Jørgen Frøkiær, Michael Borre, Kirsten Bouchelouche and Jens Sörensen

Journal of Nuclear Medicine August 1, 2019, 60 (8) 1059-1065; DOI: https://doi.org/10.2967/jnumed.118.219188
You have access
The Relationship Between Tumor Glucose Metabolism and Host Systemic Inflammatory Responses in Patients with Cancer: A Systematic Review
Ross D. Dolan, Naomi G. McLees, Ahmer Irfan, Stephen T. McSorley, Paul G. Horgan, David Colville and Donald C. McMillan

Journal of Nuclear Medicine April 1, 2019, 60 (4) 467-471; DOI: https://doi.org/10.2967/jnumed.118.216697

Main menu

User menu

Search

cancer

Pages